Four Thought Financial, LLC Reata Pharmaceuticals Inc Transaction History

Four Thought Financial, LLC

  • $677 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$20.71 - $36.5 $2,071 - $3,650
100 Added 17.15%
683 $21,000
Q3 2021

Nov 12, 2021
BUY
$100.0 - $143.02 $21,400 - $30,606
214 Added 57.99%
583 $58,000
Q1 2021

Nov 12, 2021
SELL
$94.25 - $132.81 $5,372 - $7,570
-57 Reduced 13.38%
369 $36,000
Q4 2020

Nov 12, 2021
BUY
$102.03 - $184.62 $43,464 - $78,648
426 New
426 $52,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email